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1. Introduction 
Since the development of human embryonic stem cells (hESCs) in 1998, the potential of stem 
cell-based manufacturing of tissues or organs as a form of regenerative medicine has drawn 
broad interest because hESCs are pluripotent and can proliferate infinitely without losing 
their pluripotency (Thomson et al., 1998). More recently, induced pluripotent stem cells 
(iPSCs) were generated from human fibroblasts (Takahashi et al., 2007) as well as other cell 
sources (Stadtfeld and Hochedlinger, 2010), thus accelerating the goals of research to realize 
regenerative medicine. 
Theoretically, any organ can be generated from ESCs, but the obstacles to manufacturing 
solid organs in vitro remain great. Solid organs such as kidney and liver require well-
functioning three-dimensional structures consisting of different kinds of cells as well as 
formation of and communication with blood vessels. Considering this, hematopoietic 
progenitors or mature blood cells derived from ESCs may be among the most attractive 
applications because blood cells can operate as single cells without forming a multicellular 
structure. Here, we describe methods of hematopoietic differentiation from ESCs, 
particularly focusing on hESCs, and some problems that need to be resolved before hESC-
derived blood cells can be applied in the clinical setting. 
2. Summary of hematopoietic differentiation from murine ESCs 
2.1 Hematopoietic progenitor differentiation from murine ESCs 
Since the days before and even after the development of hESCs, murine ESCs (mESCs) 
(Evans and Kaufman, 1981; Martin, 1981) have been a major tool in the study of 
differentiation of pluripotent stem cells into specialized cells. Although it is now recognized 
that there are a number of differences between mESCs and hESCs (Bhatia, 2007) and that it 
is indeed sometimes impossible to apply the differentiation protocols used in mESC 
experiments directly to those for hESCs, experiments using mESCs have provided us with 
important fundamentals for hESC research. 
Methods developed to induce hematopoietic differentiation from mESCs can be classified 
into two categories: methods that use formation of embryoid bodies (EBs) (Doetschman et 
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al., 1985) and those that use coculture with feeder cells (Gutierrez-Ramos and Palacios, 
1992). In addition, genetic manipulation was also adopted for derivation of hematopoietic 
cells from mESCs (Kyba et al., 2002; Perlingeiro et al., 2001). 
Embryoid bodies are cystic structures obtained by culturing ESC colonies in floating 
conditions in liquid or semisolid media. Hematopoietic differentiation in EBs is induced 
effectively by appropriate cytokine stimulation (Johansson and Wiles, 1995; Nakayama et 
al., 2000). In the early reports, only erythroid cells were detected in EBs (Doetschman et al., 
1985; Lindenbaum and Grosveld, 1990). In 1991, it was reported that macrophages, 
neutrophils, and mast cells were also differentiated by semisolid culture of EBs in the 
presence of interleukin (IL)-3 (Wiles and Keller, 1991). The same group reported that bone 
morphogenic protein-4 (BMP-4) mediated formation of ventral mesoderm and 
hematopoietic precursors from EBs (Johansson and Wiles, 1995). A later study revealed that 
BMP-4 promoted generation of both myeloid and lymphoid precursors from EBs, and that 
this effect of BMP-4 was enhanced by addition of vascular endothelial growth factor 
(VEGF), although VEGF alone did not have a positive effect on hematopoietic differentiation 
from EBs (Nakayama et al., 2000). 
Although EB formation is a useful method for generating hematopoietic cells with 
myelopoietic and lymphopoietic potentials, early methods using EB formation did not 
succeed in generating lymphoid progenitors. The first report of simultaneous generation of 
both myeloid and lymphoid lineages from mESCs adopted a coculture system. In this 
report, mESCs were cultured on OP9 feeder cells derived from calvaria of newborn 
(C57BL/6×C3H)F2-op/op mice without addition of exogenous cytokines (Nakano et al., 
1994). This simple culture system enabled mESCs to differentiate into hematopoietic 
progenitors that could differentiate into cells of various myeloid lineages as well as of B 
lymphocyte lineage. Thereafter, this cell line has been the standard feeder for hematopoietic 
differentiation not only from mESCs but also from hESCs. Other than OP9 cells, some cell 
lines, such as aorta-gonad-mesonephros (AGM) region-derived stromal cells (Weisel et al., 
2006) or bone marrow-derived ST2 cells (Yamane et al., 2009), were also used but the OP9 
cell-based method seems to be the most commonly used. 
To advance the understanding of regulation of hematopoietic differentiation from mESCs, 
genetic manipulation of mESCs was frequently used. To demonstrate strictly that a single 
mESC-derived hematopoietic stem cell (HSC) could produce all lineages of mature blood 
cells in vivo, clonal analysis was performed using a gene transfer protocol (Perlingeiro et al., 
2001). The chronic myeloid leukemia-associated oncogene bcr/abl was transferred to EB-
derived hematopoietic progenitors. The cells were further cultured on OP9 cells and 
thereafter cloned and transplanted into irradiated recipient mice. These cloned bcr/abl-
expressing cells differentiated into multiple myeloid lineages as well as into T and B 
lymphocytes in vivo, indicating that definitive HSCs could be generated from EB-derived 
progenitors by transformation using bcr/abl. 
A homeotic selector gene, HoxB4, proved to be a key factor in transforming EB-derived 
hematopoietic progenitors into definitive HSCs (Kyba et al., 2002). Like transformation by 
bcr/abl, ectopic expression of HoxB4 switched EB-derived primitive progenitors into 
definitive HSCs capable of long-term multilineage hematopoiesis. These approaches may 
provide further understanding of the mechanisms of HSC emergence from ESCs as well as 
from primordial cells during embryogenesis, although ESCs generated by means of genetic 
manipulation may confront further difficulties when clinical application is directly 
considered. 
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2.2 Lineage-specific differentiation of mature blood cells from murine ESCs 
In addition to HSC generation, lineage-specific differentiation of mature blood cells from 
mESCs has also been an important issue. Homogeneous populations of mESC-derived 
mature cells can be used in functional analyses and could form the basis of future hESC-
based transfusion medicine. Studying the process of differentiation from mESCs to mature 
cells can lead to understanding of normal hematopoiesis as well. Similar to HSC induction, 
mature blood cells are usually generated by EB formation, coculture with feeder cells, or a 
combination of both. Lieber et al. described an effective three-step protocol for 
differentiating mESCs into mature neutrophils (Lieber et al., 2004). First, EBs were formed 
and cultured in Iscove modified Dulbecco medium (IMDM)-based fetal calf serum (FCS)-
containing medium for 8 days. Second, the EBs were disaggregated and replated onto OP9 
cells in IMDM containing fetal bovine serum (FBS) and horse serum supplemented with 
oncostatin M, basic fibroblast growth factor (bFGF), IL-6, IL-11, and leukemia inhibitory 
factor (LIF) for 3 days. Finally, the cells were terminally differentiated on OP9 cells in IMDM 
containing platelet-depleted serum, granulocyte colony-stimulating factor (G-CSF), 
granulocyte-macrophage colony-stimulating factor (GM-CSF), and IL-6. During 7 to 14 days 
of terminal differentiation culture, 6×106 neutrophils were obtained from 8×104 mESCs.The 
purity of the mature neutrophils during this period reached 75% to 96%. These mESC-
derived mature neutrophils expressed neutrophil-specific markers (Gr-1 and others) and 
contained gelatinase- and lactoferrin-positive granules. In the functional assays, mESC-
derived neutrophils showed superoxide production and chemotaxis comparable to those of 
normal neutrophils harvested from murine bone marrow. Interestingly, neutrophils 
differentiated from MEKK1-deficient mESCs displayed impaired migratory ability. This 
result indicated that mESC-derived neutrophils could be used to study the genetic control of 
neutrophil differentiation and functions. 
As regards the application of hESC-derived mature blood cells to transfusion medicine, the 
successful treatment of anemic mice by transfusion of mESC-derived erythroid progenitors 
was of great impact (Hiroyama et al., 2008). For the differentiation, mESCs were cultured on 
OP9 cells in IMDM-based medium with VEGF and insulin-like growth factor-II. On day 4, 
dexamethasone was added, and stem cell factor (SCF), erythropoietin (EPO), and IL-3 were 
substituted for the cytokines, although IL-3 could be omitted. After long-term culture in 
these conditions, immortalized erythroid cell lines were obtained. These mESC-derived 
erythroid progenitor lines expressed adult type α- and ǃ-globins but did not express Ǆ-, ǆ-, 
and Ǉ-globins, indicating that they were adult-type erythroid cells. The erythroid 
progenitors could be differentiated in vitro into mature and enucleated cells. The erythroid 
progenitors could proliferate and differentiate in vivo, and when transplanted into anemic 
mice in which acute anemia was induced by hemolysis, the anemia ameliorated and the 
mice showed greater survival rates. Notably, no tumors were observed in the erythroid 
progenitor-transplanted mice for at least 6 months. These results are encouraging for future 
transfusion medicine using hESC-derived cells, although thorough investigation into the 
possibilities of tumorigenesis is needed. 
Megakaryocytes and platelets were effectively produced by combination of EB formation 
and coculture with OP9 cells (Nishikii et al., 2008). After EB culture for 6 days, 
megakaryocyte progenitors expressing both c-kit and integrin αIIb were sorted and further 
cultured on OP9 cells with TPO. For terminal differentiation, a mixture of TPO, IL-6, and IL-
11 was substituted for the cytokines after 3 days. Using this method, 2×105 mESCs produced 
1×106 megakaryocyte progenitors on day 6 and 2.5×106 megakaryocytes on day 12. After 2 
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to 8 days of coculture with OP9 cells, the culture supernatants contained proplatelets and 
platelets. Electron microscopy analysis revealed that they contained alpha and dense 
granules, same as platelets from adult mice. However, these mESC-derived platelets showed 
low levels of glycoprotein (GP) Ibα expression, and in the in vitro thrombus formation 
model, mESC-derived platelets had impaired ability to participate in thrombogenesis, which 
is triggered by binding of von Willebrand factor to GPIbα. Interestingly, shedding of GPIbα 
was prevented by addition of metalloproteinase inhibitors to the culture medium during 
differentiation, and this inhibition improved the thrombogenetic ability of the mESC-
derived platelets. The effect of inhibition of metalloproteinase activity was further examined 
using an in vivo model. Murine ESC-derived platelets with or without metalloproteinase 
inhibition were transfused into irradiated mice with severe thrombocytopenia. Addition of 
metalloproteinase inhibitors increased the percentage of mESC-derived platelets in the 
peripheral blood of the transfused mice. 
A simple, well-established method is used for T cell differentiation from mESCs: coculture 
with OP9 cells ectopically expressing the Notch ligand Delta-like 1 (OP9-DL1) (Schmitt et 
al., 2004). On day 14 of the coculture, mESC-derived cells contained CD4 and CD8 double-
negative (DN) T lymphocyte progenitors, and on day 20, these cells contained double-
positive (DP) cells. When mESC-derived CD25+ DN progenitors were differentiated using 
deoxyguanosine-treated fetal thymic organ culture, they generated DP T cells and CD4 or 
CD8 single-positive (SP) T cells. Furthermore, when these thymic lobes containing mESC-
derived T cells were implanted under the skin of sublethally irradiated Rag2-null mice, 
which are devoid of T and B lymphocytes, reconstitution with mESC-derived CD4 or CD8 
SP cells was observed. Infection of these mice with lymphocytic choriomeningitis virus 
(LCMV) induced LCMV-specific cytotoxic T lymphocyte activity, indicating that mESC-
derived mature T cells are capable of producing an effective antigen-specific immune 
response. As for B cells, coculture with OP9 cells induced B lineage development (Nakano et 
al., 1994), and this was enhanced by addition of Flt-3 ligand (FL) from day 5 of the coculture 
(Cho et al., 1999). After 4 weeks, more than 90% of the cells were CD45R+CD19+ B cells. In 
another report, knock down of PU.1 by small interfering RNA in CD34+ cells produced by 
EB formation induced CD19+CD43+CD45+ progenitor B (pro-B) cells (Zou et al., 2005). These 
mESC-derived pro-B cells produced precursor B (pre-B) cell colonies after a week of culture 
in a semisolid medium with IL-7 and IL-10, and a further 3-weeks culture enabled the pre-B 
cells to differentiate into mature B cells coexpressing immunoglobulin (Ig) M and CD19. 
These B cells produced by coculture with OP9 cells or by PU.1 knock down in EB cells 
showed up-regulation of CD80 and secretion of IgM by stimulation with lipopolysaccharide. 
Further detailed functional analyses, however, such as globulin class-switching, using 
mESC-derived B cells have so far not been performed. 
3. Hematopoietic stem cells derived from human ESCs 
Derivation of HSCs from hESCs, once successful, would have a great impact in both the 
clinical and basic research fields, given the wide range of potential applications. An 
unlimited amount of HSCs with various HLA and ABO blood types could be an ideal graft 
source in HSC transplantation, a starting material for manufacture of mature blood cells for 
blood transfusion, a gene transfer target for both clinical and experimental purposes, and so 
forth. 
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Besides mESCs, EB formation and coculture with feeder cells are the two major strategies 
used to produce hematopoietic cells from hESCs, although most of the protocols developed 
for mESCs cannot be applied for hESCs without significant modifications (Bhatia, 2007). For 
example, LIF is a critical factor for mESCs to be maintained in an undifferentiated state, but 
hESC maintenance is not dependent on LIF. For the maintenance of hESCs, bFGF is used, 
whereas bFGF induces neural differentiation from mESCs (Ying et al., 2003). As for the 
markers of the undifferentiated state, specific embryonic antigen (SSEA)-3 and SSEA-4 are 
used for hESCs, while SSEA-1 is used for mESCs. For hematopoietic differentiation, longer 
cultures are needed for hESCs than for mESCs. Given that species-adjusted hESC-derived 
cell transplantation experiments are impossible, evaluation of hESC-derived HSCs largely 
depends on phenotypic assays, colony-forming assays, and in vivo transplantation models 
using animals such as immunodeficient mice. Non-obese diabetic severe combined 
immunodeficiency (NOD-SCID) mice have been widely used as the hosts for 
transplantation. For evaluation of hematopoietic ability, cells are transplanted into NOD-
SCID mice and assayed by detection of SCID-repopulating cells (SRCs) (Ueda et al., 2000). 
Kaufman et al. cultured hESCs on the murine bone marrow cell line S17 or the yolk sac 
endothelial cell line C166 in a medium containing FBS without any cytokines (Kaufman et 
al., 2001). This culture enabled hESCs to differentiate into progenitors capable of producing 
colonies with multiple hematopoietic lineages. As with somatic HSCs, these colony-forming 
cells were enriched in CD34+ cells. Vodyanik et al. demonstrated that, as well as mESCs, 
hESCs could also be differentiated into CD34+ hematopoietic progenitors by coculture on 
OP9 cells (Vodyanik et al., 2005). When hESC-derived CD34+ cells were cultured on the 
murine bone marrow-derived cell line MS-5 in the presence of SCF, FL, IL-7, and IL-3, they 
could generate both myeloid and lymphoid cells. 
Chadwick et al. formed EBs from hESCs and cultured them in the presence of SCF, FL, IL-3, 
IL-6, and G-CSF, with or without BMP-4 (Chadwick et al., 2003) and found that BMP-4 
increased the number of hematopoietic progenitors from hESCs. The same group found that 
in these culture conditions including BMP-4, the primitive cells with ability to differentiate 
into both hematopoietic and endothelial cells would appear between day 7 and day 10 of the 
EB culture (Wang et al., 2004). These primitive cells expressed PECAM-1, Flk-1, and VE-
cadherin, but not CD45 (CD45-PFV). In a later report, they cultured CD45-PFV cells for 7 
days in serum-containing medium supplemented with SCF, FL, G-CSF, IL-3, and IL-6 and 
differentiated them into CD45+ cells with SRC activity (Wang et al., 2005). These hESC-
derived CD45+ cells were transplanted directly into the femurs of sublethally irradiated 
NOD-SCID mice. Even at 8 weeks after transplantation, hESC-derived SRCs were detected, 
indicating that HSCs with reconstituting ability were obtained from the hESCs. But these 
hESC-derived HSCs could not repopulate in NOD-SCID mice when they were transplanted 
intravenously. Furthermore, hESC-derived HSCs showed lower levels of chimerism in the 
transplanted bone than did the somatic HSCs from human umbilical cord blood, and the 
same pattern was seen in the contralateral femur and other long bones. These results 
indicate that hESC-derived HSCs obtained by using this method are distinct from somatic 
HSCs in terms of the ability of proliferation and migration. Notably, the authors also 
mentioned that unlike in mESCs, ectopic expression of HoxB4 in hESCs accelerated 
proliferation of hematopoietic progenitors but had no effect on the repopulating capacity of 
hESC-derived cells. 
The methods using coculture with feeder cells are also capable of generating hESC-derived 
HSCs. Tian et al. showed that hESCs cultured on S17 cells for 7 to 24 days differentiated into 
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hematopoietic cells with SRC activity even when they were transplanted intravenously 
(Tian et al., 2006). They also performed a secondary transplantation from the bone marrow 
of the primary recipient of hESC-derived HSCs into secondary donor mice and confirmed 
the long-term repopulating ability of hESC-derived HSCs. 
As mentioned above, hESCs can differentiate into hematopoietic cells with SRC activity, but 
this activity of hESC-derived cells remains low when compared with that of somatic HSCs 
such as cord blood CD34+ cells. We can thus conclude that no bona fide methods have been 
established that reproducibly generate true HSCs from hESCs. Recently, derivation of HSCs 
with higher SRC activity using a cell line derived from the AGM region was reported 
(Ledran et al., 2008). In that report, cell lines from the AGM region or fetal liver or primary 
cells from those organs were used as feeder cells. All hESC-derived hematopoietic cells 
differentiated on these feeders were capable of repopulating in immunodeficient mice when 
transplanted into the femurs of the recipient mice, and among the feeders the AGM-derived 
cell line AM20.1B4 was the best in terms of SRC activity of the hESC-derived cells. When 
this cell line was used, the chimerism of the hESC-derived cells in the peripheral blood of 
the recipient mice reached 16%. Notably, this chimerism is higher than that in previous 
reports. Considering these results, it may be important to place hESCs in an environment 
that closely mimics a hematopoietic niche in order to obtain true HSCs from them. 
4. Mature blood cells derived from human ESCs 
4.1 Neutrophils 
Neutrophil transfusion can be beneficial for severe neutropenic patients with congenital 
diseases or who have undergone chemotherapy if a sufficient number of neutrophils are 
transfused at appropriate intervals. The current blood donation system, however, is 
incapable of providing sufficient amounts of neutrophils on schedule, given that the half-life 
of neutrophils ex vivo is less than 10 hours and thus, that multiple transfusions per day are 
necessary to ensure effectiveness. Human ESC-derived neutrophils might provide a solution 
to these difficulties. They could also offer a new tool for drug discovery, drug toxicity 
monitoring, and so on. Recently, a method to obtain mature neutrophils with high purity 
from hESCs was developed (Yokoyama et al., 2009). 
The culture system consisted of 2 phases: EB formation and OP9 coculture with different 
combinations of cytokines at each phase. For the formation of EBs, hESC colonies were 
detached from the mouse embryonic fibroblasts used as feeder cells to maintain the hESCs, 
using collagenase. The removed colonies were then cultured in the IMDM-based medium 
for HSC expansion (Suzuki et al., 2006) in a serum-free condition, which resulted in the 
initial formation of EBs within 24 hours. The resulting EBs were collected and cultured for 
17 days in IMDM containing 15% FBS supplemented with BMP-4, SCF, FL, IL-6/IL-6 
receptor fusion protein (FP6), and TPO. For the preparation of feeder cells, irradiated OP9 
cells were next plated onto gelatin-coated 6-well tissue culture plates at a density of 
1.5×105/well 24 hours before use. The EBs were dissociated into single cells and suspended 
in IMDM containing 10% FBS and 10% horse serum supplemented with a combination of 
SCF, FL, FP6, IL-3, and TPO. Then, up to 5×105 EB-derived cells were seeded in a well with 
the OP9 cell layer. After 7 days, floating cells were collected, suspended in IMDM 
containing 10% FBS and G-CSF, and transferred onto the newly irradiated OP9 cells. 
Terminally differentiated cells were harvested 6 or 7 days later. 
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As determined by morphology, most of the hESC-derived cells at day 7 of the final coculture 
with OP9 cells were myeloblasts and promyelocytes. On days 9 through 11, myeloblasts and 
metamyelocytes were dominant. On days 13 and 14, 70% to 80% of the total cell population 
were differentiated mature neutrophils and the remaining 10% to 20%, metamyelocytes. 
Transmission electron microscopic observation also revealed characteristic segmented nuclei 
and cytoplasmic granules. On days 13 and 14, Wright-Giemsa staining also revealed that up 
to 10% of the cells were monocyte- or macrophage-like cells, but no other cell lineages such 
as erythrocytes, megakaryocytes, or lymphocytes were observed throughout the culture. 
Thus, this differentiation protocol made it possible to obtain hESC-derived neutrophils at a 
high purity. These hESC-derived neutrophils were positively stained for myeloperoxidase, 
which is a major constituent of the primary granules of neutrophils. Biosynthesis of 
lactoferrin, which is a major constituent of the secondary granules, was analyzed by 
comparison of mRNA expressions of the hESC-derived cells with those of mature 
neutrophils from the peripheral blood and mononucleated cells from the bone marrow of 
healthy volunteers. Lactoferrin mRNA was expressed in hESC-derived cells as early as day 
7 of the final induction culture on OP9 cells, peaked at day 10, and declined at days 13 and 
14. This pattern was consistent with the documented pattern of lactoferrin biosynthesis 
(Rado et al., 1984). These patterns of morphological maturation and lactoferrin mRNA 
expression during the culture indicated that hESC-derived cells differentiated into mature 
neutrophils by a process similar to physiologic neutrophil production, and thus, this method 
could be used to investigate the differentiation process of neutrophils. 
 
 
Fig. 1. Neutrophils derived from hESCs. (A) Wright-Giemsa staining of the hESC-derived 
cells at days 7 (i), 9 (ii), 11 (iii), and 13 (iv). (B) The hESC-derived neutrophils stained 
positive for myeloperoxidase and alkaline-phosphatase. This research was originally 
published in Blood. Yokoyama et al.. Derivation of functional mature neutrophils from 
human embryonic stem cells. Blood. 2009;113:6584-6592. © the American Society of 
Hematology. 
Surface antigen expression of hESC-derived cells was analyzed at different time points by 
flow cytometry. The pattern of antigen expression was almost consistent with that of normal 
neutrophil differentiation, except for some G-CSF-related changes. Almost all the cells 
expressed the common blood cell antigen CD45 from days 7 through 13. A small population 
expressed the markers of immature hematopoietic cells such as CD34, CD117, and CD113 at 
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day 7 but lost the expression by day 10. The common myeloid antigens CD33 and CD15 
were highly expressed from days 7 through 13, whereas CD11b expression increased as 
maturation proceeded. CD13 is also a common myeloid antigen, but only fewer than 20% of 
the cells expressed CD13 throughout the final culture. CD16 (FcǄ receptor [FcǄR] III) is 
frequently used as the marker of mature neutrophils; it was already found on hESC-derived 
cells at day 7 and increased with maturation, which is consistent with the physiologic 
neutrophil maturation process. However, the proportion of CD16+ cells was lower than that 
of the morphology-defined mature neutrophils on day 13. Other FcǄ receptors, CD32 
(FcǄRII) and CD64 (FcǄRI), were also expressed on hESC-derived neutrophils. CD14 was 
expressed in 20% to 25% of the cells on days 10 and 13. In normal peripheral blood, mature 
neutrophils express CD16 but not CD64 and CD14 (van de Winkel and Anderson, 1991; van 
Lochem et al., 2004), but some of the hESC-derived mature neutrophils expressed CD14, but 
not CD16, and most of the cells expressed CD64. This aberrant expression pattern is similar 
to that of the neutrophils harvested from healthy donors who received G-CSF (Carulli, 1997; 
Kerst et al., 1993) and of the neutrophils derived from bone marrow CD34+ cells in vitro by 
G-CSF stimulation (Kerst et al., 1993), and thus, hESC-derived neutrophils were thought to 
be also affected by G-CSF during the final culture. 
The high purity and yield enabled subsequent functional analyses of the hESC-derived 
neutrophils. As seen in the expression of surface antigens, G-CSF used in the induction 
culture might affect the functions of hESC-derived neutrophils. Therefore, hESC-derived 
neutrophils were restimulated with G-CSF before the assay and compared with peripheral 
blood neutrophils with and without G-CSF stimulation. 
Chemotaxis is the first step in innate immune system by neutrophils and important for 
neutrophils to be able to move to the inflammatory site effectively. Chemotaxis was 
analyzed using a modified Boyden chamber method (Harvath et al., 1980). In this method, 
reaction medium with or without chemotactic factor formyl-Met-Leu-Phe (fMLP) was 
placed into each well of a 24-well plate, and a semipermeable membrane with 3.0-μm pores 
was placed into each well to divide the well into upper and lower sections. Neutrophils 
were added to the upper section and allowed to migrate from the upper to the lower side of 
the membrane. After incubation, the number of neutrophils on the lower side of the 
membrane was counted. The neutrophils that migrated to the lower side without fMLP 
were considered to have migrated randomly. This random migration of peripheral blood 
neutrophils was accelerated by G-CSF, but, despite the stimulation by G-CSF, the hESC-
derived neutrophils showed an extent of random migration that was only similar to that of 
the peripheral blood neutrophils without G-CSF stimulation. The number of cells that 
showed chemotaxis to fMLP was calculated by subtracting the number of migrated cells 
without fMLP from that of migrated cells with fMLP. This chemotaxis was not significantly 
different between hESC-derived neutrophils and peripheral blood neutrophils with or 
without G-CSF stimulation. 
The next step in innate immune system by neutrophils is phagocytosis, and subsequently, 
killing of ingested microorganisms occurs mainly depending on superoxide production. We 
adopted a unique assay that simultaneously visualizes phagocytosis and superoxide 
production. Autoclaved baker’s yeast was suspended in 0.5% nitroblue tetrazolium (NBT) 
solution (0.5% NBT and 0.85% sodium chloride in distilled water). When these NBT-coated 
yeasts are ingested by neutrophils, the yeasts change their color from brown to purple or 
black because of reduction of NBT and formation of formazan in response to superoxide 
produced by neutrophils. We incubated these NBT-coated yeasts with hESC-derived and 
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peripheral blood neutrophils. Ingested yeast cells that changed color in the cells were NBT-
reaction positive. The difference in the number of positive yeasts yeilded by the hESC-
derived neutrophils and peripheral blood neutrophils was not significant. G-CSF 
stimulation had no effect on the peripheral neutrophils in this assay. 
Superoxide production by oxidative burst is the most important function for neutrophils to 
perform efficient bactericidal activity. In addition to the above-mentioned NBT reduction, 
we used dihydrorhodamine123 (DHR) to evaluate superoxide production. In the test, DHR 
was added to the neutrophil suspension with or without stimulation by phorbol myristate 
acetate (PMA), and rhodamine fluorescence from the oxidized DHR was detected by flow 
cytometry (Richardson et al., 1998). When DHR was added to the neutrophil suspensions, 
rhodamine-specific fluorescence was detected, indicating basal production of superoxide 
without PMA stimulation. Stimulation by PMA strongly increased rhodamine fluorescence 
in hESC-derived neutrophils and peripheral blood neutrophils, indicating that hESC-
derived neutrophils had sufficient capability of superoxide production and adequate 
response to stimulation. 
Finally, we evaluated actual bactericidal activity in vitro using viable Escherichia coli (Decleva 
et al., 2006). Opsonized E coli were added to the neutrophil suspension at a 
neutrophil/bacteria ratio of 2:1 or to the control medium. After 1 hour of incubation, the 
neutrophils were lysed, and the samples were added to molten tryptic soy broth with 1.5% 
agar and plated on dishes. The colonies derived from the surviving E coli were counted after 
overnight incubation. When the E coli were incubated with hESC-derived neutrophils and 
peripheral blood neutrophils with or without G-CSF stimulation, the numbers of the 
colonies were similarly reduced to approximately 40% those of the control, indicating that 
the hESC-derived neutrophils had bactericidal activity against E coli comparable to that of 
normal neutrophils. 
Generation of functional neutrophils using a feeder-free culture system was also reported by 
another group (Saeki et al., 2009). In this method, EBs were cultured in IMDM 
supplemented with FBS, insulin-like growth factor II, VEGF, SCF, FL, TPO, and G-CSF. 
After 3 days, the EBs were transferred onto gelatin-coated dish and cultured in the same 
medium as that of the EB culture. After 2 weeks of adherent culture on the gelatin-coated 
dish, sac-like structures (SLSs) emerged, and within a few days, round cells appeared in the 
sacs. These round cells had the potential to produce granulocyte, macrophage, or erythroid 
colonies. After 4 to 6 weeks of adherent culture, immature and mature myeloid cells were 
obtained, including mature neutrophils, although the purity of the mature neutrophils was 
relatively low (30%-50%). These hESC-derived neutrophils showed chemotaxis to fMLP and 
IL-8, phagocytosis of zymosan, and NBT-reduction. Interestingly, the authors of this report 
evaluated the chemotactic activity in vivo using a zymosan-induced air pouch inflammation 
model (Doshi et al., 2006). In this model, neutropenia was induced in immunodeficient 
NOD-SCID/Ǆcnull (NOG) mice by injection of 5-fluorouracil, and a subcutaneous air pouch 
was formed on the back of the NOG mice. After 3 days, 2×106 hESC-derived or human cord 
blood CD34-positive cells were transfused. Injection of both zymosan and IL-1ǃ into the air 
pouch caused inflammation of the pouch, and accumulation of neutrophils in the pouch was 
observed. Among the massive murine neutrophils, hESC-derived neutrophils accounted for 
0.54% of the total cells that were accumulated in the pouch. This percentage was the same as 
that for cord blood CD34+ cells. For the establishment of fundamentals for clinical 
application, in vivo analysis of neutrophil functions, especially the bactericidal activity and 
prolongation of survival of infected mice by neutrophil transfusion, is needed. 
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4.2 Erythrocytes 
Adult-type erythrocytes derived from hESCs could be a new and ideal transfusion source if 
large-scale production can be achieved, given that they could be free from infectious 
organisms. Furthermore, hESC-derived erythrocytes from rare blood-type donors might 
resolve the difficulty of availability of such types of RBCs. 
In normal human erythroid development, the expression pattern of hemoglobin subunits in 
erythrocytes changes according to the developmental stage. In primitive yolk sac 
erythropoiesis, embryonic-type Ǉ– and ǆ–globin are expressed. In definitive erythropoiesis, 
Ǉ–globin and ǆ–globin switch to fetal-type α-globin and Ǆ-globin, respectively, and Ǆ-globin 
further switches to adult-type ǃ-globin (Peschle et al., 1985). When evaluating erythrocytes 
derived from hESCs, in addition to the efficiency of the induction culture, it is important to 
examine the globin expression pattern to determine the erythrocyte type. 
As described in section 3, culturing EBs in the presence of SCF, FL, IL-3, IL-6, G-CSF, and 
BMP-4 accelerates the generation of hematopoietic progenitors (Chadwick et al., 2003), and 
when VEGF was added to these basal cytokines, both the number and the frequency of 
erythroid colonies derived from the EBs were augmented (Cerdan et al., 2004). Evaluation of 
globin expression by detection of mRNA of each globin revealed that the cells from EBs 
treated with only basal cytokines expressed only ǆ-globin, but addition of VEGF to the basal 
cytokines promoted expression of both ǆ- and Ǉ-globins. ǃ-globin expression was not proven 
in either culture condition. Thus, the erythropoiesis in the EBs cultured with this 
combination of cytokines was thought to recapitulate primitive erythropoiesis with 
embryonic globin expression. However, the erythrocytes picked up from the EB-derived 
erythroid colonies in a semisolid culture expressed ǃ-globin in addition to ǆ-globin, but not 
Ǉ-globin, indicating the possibility of globin switch during the colony-formation culture. 
Expression of embryonic and fetal globins, but not adult ǃ-globin in hESC-derived 
erythrocytes was also reported by different groups (Chang et al., 2006; Olivier et al., 2006).  
Other groups showed successful expression of ǃ-globin in hESC-derived erythrocytes. Ma et 
al. developed an efficient method of inducing erythrocytes using coculture with feeder cells 
(Ma et al., 2007; Ma et al., 2008). In this method, the hESC colonies were cultured on 
irradiated primary murine fetal liver stromal cells without any cytokines. At days 11 to 12, 
hESC-derived cells formed SLSs containing hematopoietic cobblestone-like cells. On day 14, 
1×104 original hESCs had given rise to 1×106 total cells including 5×103 cobblestone-like cells. 
When the mixture of stromal cells and all hESC-derived cells were prepared as a single cell 
suspension and cultured in a semi-solid medium with EPO, SCF, IL-3, IL-6, TPO, and G-
CSF, they generated mainly erythroid colonies including erythroid bursts, although 
approximately 25% were non-erythroid colonies. Erythroid bursts accounted for about 5% of 
the total colonies, and each large erythroid burst contained approximately 2×105 erythroid 
cells. Importantly, about 60% of the hemoglobin-containing erythroid cells in each erythroid 
burst derived from hESC after 12-day co-culture on murine fetal liver stromal cells 
expressed adult ǃ-globin, and the proportion reached nearly 100% when the coculture was 
extended to 18 days. In contrast, the proportion of ǆ-globin-expressing erythroid cells in 
each erythroid burst decreased from 100% to 60%. Globin switch could also be observed 
when the day 12-erythroid bursts were transferred to a suspension culture for an additional 
6 days; the expression of ǆ-globin decreased, whereas ǃ-globin expression increased to about 
100%, and, notably, ǃ-globin-expressing enucleated RBCs were observed. The hESC-derived 
erythroid cells could function as oxygen carriers showing oxygen dissociation curves similar 
to those of human cord blood RBCs, although their curves were left-shifted when compared 
www.intechopen.com
Hematopoietic Differentiation from Embryonic Stem Cells   
 
261 
to those of adult peripheral blood RBCs. The hESC-derived erythroid cells had higher 
glucose-6-phosphate dehydrogenase activity than did the adult peripheral blood RBCs. 
Lu et al. showed two methods of producing erythrocytes using hemangioblasts derived 
from hESCs as starting materials: one, the massive production of nucleated erythrocytes 
without adult ǃ-globin expression, and the other, induction of enucleation of hESC-derived 
erythrocytes with some ǃ-globin expression (Lu et al., 2008). By the method for massive 
production, they generated 1010 to 1011 erythrocytes from one 6-well plate of hESCs. In the 
first step, EBs were formed and cultured in serum-free medium containing BMP-4, VEGF, 
and bFGF. After 48 hours, half the medium was exchanged for fresh medium with the same 
cytokines and additional SCF, TPO, and FL, and cultured for a further 36 hours. In the 
second step, EBs were then dissociated into single cells, which were cultured for 10 days in 
blast-colony growth medium (BGM) consisting of IMDM, 1.0% methylcellulose, bovine 
serum albumin, insulin, iron-saturated transferrin, GM-CSF, IL-3, IL-6, G-CSF, EPO, SCF, 
VEGF, and BMP-4. Dependent on the hESC lines, TPO and FL were added to the cytokine 
combination. This culture condition induced and expanded the hESC-derived 
hemangioblasts that had been described in a previous report (Lu et al., 2007). To optimize 
the method, they used a fusion protein consisting of HoxB4 and triple protein-transduction 
domains (tPTD-HoxB4). The PTD used here was a modified form of PTD embedded in the 
transactivator of transcription protein of the human immunodeficiency virus (Ho et al., 
2001; Lu et al., 2007). Maximum efficiency was achieved when tPTD-HoxB4 and bFGF were 
added to the BGM. In the third step, equal volumes of BGM containing additional EPO were 
added to the existing BGM, and the cells were further cultured and differentiated into 
erythroid cells for 5 days. The erythroid cells were then transferred to serum-free medium 
containing SCF, EPO, and 0.5% methylcellulose, and expanded for 7 days. In the final step, 
for the purification of the erythroid cells, the resulting cells were plated in tissue culture 
flasks overnight to allow nonerythroid cells to attach to the flasks, and the nonadherent cells 
were collected. By this method, numerous erythroid cells (1010 to 1011 cells from one 6-well 
plate of hESCs) could be obtained; however, these hESC-derived erythroid cells were 
nucleated and contained embryonic Ǉ- and ǆ-globins, and fetal GǄ-globin, but neither fetal 
AǄ-globin nor adult ǃ-globin. Nevertheless, the hESC-derived erythroid cells showed an 
oxygen equilibrium curve comparable to that of normal adult RBCs. 
A modification of this method allowed enucleated hESC-derived erythrocytes with adult ǃ-
globin to be obtained. The protocols in the first step and up to day 7 in the second step were 
the same. After 7 days of culture in the second step, the cells were cultured in serum-free 
medium containing bovine serum albumin, inositol, folic acid, transferrin, insulin, ferrous 
nitrate, and ferrous sulfate, and supplemented with hydrocortisone, SCF, IL-3, and EPO. 
After 7 days, SCF and IL-3 were removed. In these conditions, 10% to 30% of the hESC-
derived erythrocytes were enucleated. Importantly, considering that the hESCs were 
maintained without feeder cells, the enucleated erythrocytes were generated in completely 
feeder-free conditions. By this method, however, hESCs showed expansion of only 30- to 50-
fold. Furthermore, even after enucleation, the hESC-derived erythrocytes expressed mainly 
embryonic Ǉ- and ǆ-globins, and fetal Ǆ-globin, but not ǃ-globin. However, survival and 
enucleation of the erythrocytes were enhanced when they were cocultured on OP9 cells, and 
long-term culture of the cells induced adult ǃ-globin expression from 0% at day 17 to 16% at 
day 28, indicating the potential of globin switch of hESC-derived erythrocytes.  
Dependent on the methods, the expression patterns of the hemoglobin subunits were 
different. Comparison of the methods would be useful to understanding the mechanisms of 
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erythroid development and globin switch. If hESC-derived fetal erythrocytes could be 
successfully changed to adult erythrocytes and high efficiency achieved, it would open up 
the way to clinical use. 
 
 
Fig. 2. Erythrocytes derived from hESCs. (A) Erythrocytes derived from 2×106 hESCs. (B) 
Suspension of erythrocytes from panel A in equivalent hematocrit of human whole blood. 
(C, D) Wright-Giemsa staining of hESC-derived erythrocytes. Original magnification, C: 
×200, D: ×1000. This research was originally published in Blood. Lu et al.. Biologic properties 
and enucleation of red blood cells from human embryonic stem cells. Blood. 2008;112:4475-
4484. © the American Society of Hematology. 
4.3 Megakaryocytes and platelets 
Platelet derivation from hESCs is also of concern for transfusion medicine. Platelets can be 
stored for only 3 to 4 days, and more donors are needed to secure sufficient amounts of 
platelet concentrates than are needed for RBCs. Two groups so far reported specific methods 
for megakaryocyte/platelet derivation from hESCs, and both used coculture with feeder 
cells (Gaur et al., 2006; Takayama et al., 2008). In the first report, small clumps of hESCs 
were cultured on OP9 cells in the presence of 100 ng/mL TPO. The cells were transferred 
onto fresh OP9 cells on days 7 and 11. After 15 to 17 days of culture, 20% to 60% of the 
hESC-derived cells were positive for both CD41a and CD42b, which are representative 
markers of the megakaryocyte lineage. In this culture, 1×105 starting hESCs yielded 1 to 
4×104 CD41a+CD42b+ cells. These cells showed megakaryocytic morphology with 
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polyploidy. The hESC-derived megakaryocytes showed substantial increase of fibrinogen-
binding capacity compared to baseline in response to thrombin receptor-activating agonists 
or adenosine di-phosphate. This result indicated the presence of appropriate inside-out 
signaling of integrin ǂIIbǃ3 in hESC-derived megakaryocytes, which controls affinity and 
avidity of integrin ǂIIbǃ3 for fibrinogen. Moreover, when hESC-derived megakaryocytes 
were plated on fibrinogen-coated glass cover slips, they showed extensive lamellipodia 
formation, F-actin formation, and vinculin localization, indicating proper outside-in 
signaling of integrin ǂIIbǃ3. However, these apparently functional megakaryocytes rarely 
differentiated to proplatelets. These data imply that terminal differentiation to mature 
platelets might not be observed in this culture system. On the other hand, Takayama et al. 
confirmed the first report of the derivation of megakaryocytes from hESC using coculture 
with OP9 cells, and developed a new method of generating megakaryocytes capable of 
releasing platelets (Takayama et al., 2008). Coculture of hESCs on either C3H10T1/2 or OP9 
cells without transfer to new feeders for 2 weeks led to emergence of SLSs. Addition of 
VEGF to the culture medium increased the number of the SLSs. These SLSs contained 
hematopoietic progenitors with multilineage colony-forming potential, and those 
progenitors could be further differentiated into mature proplatelet-forming megakaryocytes 
when transferred onto new feeder cells and cultured in the presence of TPO for an 
additional 7 to 9 days. CD41a+CD42b+ platelets were then detected in the culture 
supernatants. The maximum yield was achieved when the medium was supplemented with 
SCF and heparin in addition to TPO, resulting in approximately 5×106 platelets produced 
from 105 hESCs. The hESC-derived platelets had appropriate inside-out and outside-in 
signaling of integrin ǂIIbǃ3. This method is expected to be useful for studies of the 
developmental mechanisms and functions of megakaryocytes and platelets, and for 
transfusion medicine, although extreme improvement in the efficiency of platelet generation 
from hESCs is needed. 
 
 
Fig. 3. Sac-like structures and megakaryocytes derived from hESCs. (A) Sac-like structures 
with distinct morphology. They contained hematopoietic progenitors. (B) Megakaryocytes 
derived from hESC. This research was originally published in Blood. Takayama et al. 
Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, 
VEGF-promoted structures that concentrate hematopoietic progenitors. Blood. 2008;111:5298-
5306. © the American Society of Hematology. 
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4.4 Natural killer cells 
Natural killer (NK) cells have cytotoxic enzymes and play a major role in innate immunity. 
They also have antitumor activity, and the possibility of safe and efficaciously adoptive 
immunotherapy using NK cells has been shown in the setting of allogeneic hematopoietic 
stem cell transplantation or studies of NK cell transfusion for malignancies (Ljunggren and 
Malmberg, 2007; Miller et al., 2005; Ruggeri et al., 2002). Derivation of NK cells with 
antitumor activity from hESCs could be a possible means of immunotherapy. The most 
functional hESC-derived NK cells so far were generated by sequential coculture on different 
feeder cells (Woll et al., 2005; Woll et al., 2009). Firstly, hESCs were cultured on S17 or a 
murine bone marrow stromal cell line M210-B4 for 17 to 20 days. After the first coculture, 
CD34+CD45+ cells were sorted and transferred to a murine fetal liver-derived stromal cell 
line, AFT024, and cocultured in medium containing human AB blood-type serum with a 
cytokine cocktail consisting of IL-3, SCF, IL-15, FL, and IL-7. At 3 to 5 weeks of culture, 
approximately 70% of the hESC-derived cells were CD45- and CD56-positive NK cells, with 
expression of receptors typically found on adult NK cells such as CD16, CD94, NKp46, and 
killer-cell Ig-like receptors (KIR or CD158). Interestingly, hESC-derived NK cells showed 
higher cytolytic activity against various tumor and leukemia cell lines than did NK cells 
derived from cord blood progenitors under the same conditions. Higher antileukemic 
activity in vivo with hESC-derived NK cells was also demonstrated in a mouse model for 
human leukemia using the human erythroleukemia cell line K562. These results indicate 
that hESC-derived NK cells are potentially a good source for immunotherapy. 
4.5 T and B lymphocytes and other lineages 
T and B cells have central roles in acquired immunity, but derivation of these cells from 
hESCs could be more difficult than that of cells of other lineages. As described in section 2. 
2, mESCs can be easily differentiated into T cells using OP9-DL1 cells. However, Martin et 
al. reported that hESC-derived CD34+ progenitors could not be differentiated into the T-cell 
lineage in vitro even by co-culture with OP9-DL1 cells or by fetal thymic organ culture 
(Martin et al., 2008). The first successful specific derivation of mature T cells from hESCs 
was achieved by an in vivo procedure using SCID-hu mice (Galic et al., 2006). The SCID-hu 
mice were constructed by insertion of human fetal thymus and liver under the renal capsule 
of SCID mice, and provide the environment for T lineage differentiation (Akkina et al., 1994; 
McCune et al., 1988). Human ESC-derived CD34+ or CD34-CD133+ hematopoietic 
progenitors, obtained by coculture with OP9 cells for 7 to 14 days, were injected into 
thymus/liver implants in sublethally irradiated SCID-hu mice. After 3 to 5 weeks, biopsy of 
the thymus/liver implants demonstrated repopulation of hESC-derived cells in the implants 
accounting for up to 6.2% of the total cells. Phenotypic analysis revealed differentiation of 
hESCs into immature CD4+CD8+ T cells and mature CD4+CD8- and CD8+CD4- T cells. Later, 
the same group modified the methods and adopted EB formation instead of coculture with 
OP9 cells (Galic et al., 2009), and they showed normal V(D)J recombination during 
differentiation of hESC-derived T cells and CD25 expression on the cells in response to 
stimulation. However, complicated and cumbersome in vivo procedures, particularly the use 
of human fetal thymus and liver, obviously hamper the further progress of the study of 
hESC-derived T-cell development.  
Contrary to the previous report by Martin et al., Timmermans et al. reported an in vitro 
method of T cell differentiation using coculture with OP9-DL1 (Timmermans et al., 2009). In 
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this method, hESCs were cocultured on OP9 cells. After 10 to 12 days, endothelium-lined 
cell clumps emerged that resembled the hESC-derived SLSs described in Takayama’s 
method of megakaryocyte differentiation. These structures were transferred onto OP9-DL1 
cells and cultured in medium supplemented with FL, IL-7, and SCF. After 14 days of 
coculture on OP9-DL1 cells, CD4 SP cells and CD4 CD8αα DP cells were detected within the 
cytoplasmic CD3ǆ+CD5+ cell population. After 21 days, CD4 CD8αǃ DP cells appeared, and 
on day 28, DP cells accounted for 25% of the cells. After 30 days of culture, 15% to 50% of 
hESC-derived cells were T lineage cells expressing surface CD3 and TCRαǃ. In addition to 
the CD3+TCRαǃ+ cells, CD3+TCRǄǅ+ cells also emerged. These results suggested that hESC-
derived T cells differentiated phenotypically in a way similar to that in thymic development. 
In response to stimulation, hESC-derived T cells showed a 2,500-fold increase, and all 
surface CD3+ T cells had the mature CD27+CD1a- phenotype. Restimulation of the expanded 
T cells induced interferon-Ǆ production. These results indicated that phenotypically and 
functionally mature T cells could be generated from hESCs, although detailed functional 
analyses have yet to be performed. 
B cell differentiation from hESCs is also challenging compared with that of other lineages. 
No effective methods for achieving B cell differentiation from hESCs have so far been 
devised. Martin et al. reported that hESC-derived CD34+ hematopoietic progenitors lacked B 
lineage differentiation capability when cocultured with MS-5 cells that support B cell 
differentiation from cord blood CD34+ progenitors (Martin et al., 2008). Thus, an additional 
cue is required to establish an environment sufficient for B cell differentiation, in addition to 
the cytokines and feeders that have been used so far. Given the success in B cell 
differentiation from mESCs, differences between mESCs and hESCs or species specificities 
of the feeder cell-expressed proteins may explain this hurdle.  
Other lineages of blood cells, such as macrophages (Anderson et al., 2006) and dendritic 
cells (Slukvin et al., 2006), can also be generated from hESCs. As described in this section, 
hESC-derived mature blood cells including neutrophils, erythrocytes, megakaryocytes, and 
NK cells are commonly very similar to their normal counterparts in morphology, 
phenotype, and function. Therefore, if sufficient amounts of mature blood cells derived from 
hESCs can be obtained, they can be expected to be used for a variety of purposes, for 
example, as substitutes for normal blood cells for in vitro drug screening and as blood 
transfusion sources.  
5. Future directions 
Coculture with feeder cells and EB formation are the two major strategies for hematopoietic 
differentiation from hESCs commonly used to generate both progenitors and mature blood 
cells. However, no methods for generating bona fide HSCs from hESCs have yet been 
established, despite the fact that feeder cells derived from bone marrow, fetal liver, and 
AGM should provide a hematopoietic microenvironment similar to the physiologic one. As 
regards the preparation of an ideal microenvironment for inducing HSCs from hESCs, the 
combined use of an in vitro culture system with an animal body may prove a powerful 
method. Recently, a sensational report of the generation of rat pancreas in mouse was 
published (Kobayashi et al., 2010). Injection of rat wild-type iPSCs into blastocysts of a Pdx1-
null mouse, which is devoid of pancreas and dies soon after birth, resulted in the 
development of a compensatory pancreas entirely derived from rat iPSCs. This result 
indicated that when a developmental niche for a certain organ is empty, pluripotent stem 
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cell-derived cells can occupy the niche and compensate for the missing organ. Considering 
application of this finding for hematopoiesis, it may be possible to obtain pluripotent stem 
cell-derived HSCs using a mouse that is devoid of HSCs, for example, GATA2- (Tsai et al., 
1994), SCL/Tal1- (Porcher et al., 1996), Runx1/AML1- (Okuda et al., 1996), or Notch1- 
(Kumano et al., 2003) null mice. This approach of interspecific blastocyst complementation 
might contribute to overcoming the issue of yield, which still represents a high barrier to 
reaching clinical applications. If large animals, such as pigs, without hematopoietic ability 
become available, injection of human ESCs or iPSCs into their blastocysts might make it 
possible to obtain massive amounts of human HSCs and mature blood cells, although 
contamination with xenogeneic constituents is still a problem, and ethical arguments must 
be addressed before proceeding to the generation of human-animal hybrid embryos, 
particularly given that human cells could be differentiated into mature cells other than 
blood cells in the animal. 
To achieve magnitudes of increase in cell number yields, which is necessary for virtually all 
the protocols hitherto reported, one potential goal is generation of progenitor cell lines that 
can proliferate infinitely and produce mature blood cells. As described in section 2. 2, 
mESC-derived erythroid progenitor lines could differentiate into functional mature red 
blood cells both in vitro and in vivo and ameliorate anemia in mice (Hiroyama et al., 2008). 
Although these erythroid progenitor lines were generated by coculturing with feeder cells 
under cytokine stimulation, genetic manipulation of hESCs or their progenies can also be 
considered. Gene manipulation has a risk of causing tumorigenesis; however, this concern is 
much smaller in the case of RBCs and platelets, given that these are unnucleated cells. 
With the accumulated findings of hematopoietic differentiation from hESCs, hESC-derived 
HSCs and mature blood cells are now or will soon be good resources for functional analyses, 
drug-screening tests, research into the differentiation process, and so forth. Remarkable 
progresses in this field are continuously being made, which is encouraging for the 
achievement of clinical application of hESC-derived blood cells in the not-too-distant future. 
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